Exagen Inc.2024财年第二财季实现净利润-2.97百万美元，同比增加40.72%

自选股智能写手08-12

8月12日，Exagen Inc.（XGN.US）公布财报，公告显示公司2024财年第二财季净利润为-2.97百万美元，同比增加40.72%；其中营业收入为15.06百万美元，同比增加6.51%，每股基本收益为-0.16美元。从资产负债表来看，Exagen Inc.（XGN.US）总负债31.72百万美元，其中短期债务1.82百万美元，资产负债比为1.56，流动比率为4.32。机构评级：截至...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2458169215?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-12 00:09","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2458169215","market":"us","top_or_hot":-1,"title":"Exagen Inc.2024财年第二财季实现净利润-2.97百万美元，同比增加40.72%","media":"自选股智能写手","content":"<div>\n<p>8月12日，Exagen Inc.（XGN.US）公布财报，公告显示公司2024财年第二财季净利润为-2.97百万美元，同比增加40.72%；其中营业收入为15.06百万美元，同比增加6.51%，每股基本收益为-0.16美元。从资产负债表来看，Exagen Inc.（XGN.US）总负债31.72百万美元，其中短期债务1.82百万美元，资产负债比为1.56，流动比率为4.32。机构评级：截至...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120009159590416e&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Exagen Inc.2024财年第二财季实现净利润-2.97百万美元，同比增加40.72%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nExagen Inc.2024财年第二财季实现净利润-2.97百万美元，同比增加40.72%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-12 00:09 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120009159590416e&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月12日，Exagen Inc.（XGN.US）公布财报，公告显示公司2024财年第二财季净利润为-2.97百万美元，同比增加40.72%；其中营业收入为15.06百万美元，同比增加6.51%，每股基本收益为-0.16美元。从资产负债表来看，Exagen Inc.（XGN.US）总负债31.72百万美元，其中短期债务1.82百万美元，资产负债比为1.56，流动比率为4.32。机构评级：截至...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120009159590416e&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XGN","symbol_name":"Exagen","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120009159590416e&s=b","article_id":"2458169215","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120009159590416e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2458169215","pubTimestamp":1723392545,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"8月12日，Exagen Inc.公布财报，公告显示公司2024财年第二财季净利润为-2.97百万美元，同比增加40.72%；其中营业收入为15.06百万美元，同比增加6.51%，每股基本收益为-0.16美元。从资产负债表来看，Exagen Inc.总负债31.72百万美元，其中短期债务1.82百万美元，资产负债比为1.56，流动比率为4.32。机构评级：截至2024年8月12日，当前有4家机构对Exagen Inc.目标价做出预测，其中目标均价为6.25美元，其中最低目标价为5.00美元，最高目标价为8.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"XGN":"Exagen"},"translate_title":"Exagen Inc. achieved net profit of-2.97 million US dollars in the second fiscal quarter of fiscal year 2024, a year-on-year increase of 40.72%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XGN":1},"content_text":"8月12日，Exagen Inc.（XGN.US）公布财报，公告显示公司2024财年第二财季净利润为-2.97百万美元，同比增加40.72%；其中营业收入为15.06百万美元，同比增加6.51%，每股基本收益为-0.16美元。从资产负债表来看，Exagen Inc.（XGN.US）总负债31.72百万美元，其中短期债务1.82百万美元，资产负债比为1.56，流动比率为4.32。机构评级：截至2024年8月12日，当前有4家机构对Exagen Inc.目标价做出预测，其中目标均价为6.25美元，其中最低目标价为5.00美元，最高目标价为8.00美元。公司简介：Exagen Inc 是一家商业阶段的诊断公司，致力于解决自身免疫性风湿病患者进行准确诊断和监测的时的未满足需求。 目前该公司在其 Avise 品牌下销售十种检测产品，以提供准确、及时的鉴别诊断并优化急性呼吸道疾病（ARDs）的治疗。该公司向社区风湿病学家推销和销售解决方案。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.28.1","shortVersion":"4.28.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2458169215"}